MRK - Merck & Co., Inc.


119.83
-1.580   -1.319%

Share volume: 9,276,447
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$121.41
-1.58
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-03-2024 08-05-2024 11-06-2024 02-25-2025 05-02-2025 08-05-2025 11-05-2025 02-24-2026
Cash flow financing -2.814 B 1.216 B -2.425 B -3.009 B -5.755 B -3.556 B 2.638 B 4.751 B
Other financing cash flows 87.000 M 73.000 M 5.000 M 12.000 M 19.000 M 12.000 M 14.000 M 47.000 M
Cash flow -1.100 B 5.784 B 3.021 B -1.003 B -4.742 B -1.033 B 10.177 B -3.593 B
Net income 4.767 B 5.461 B 3.161 B 3.744 B 5.085 B 4.428 B 5.787 B 2.963 B
Depreciation 511.000 M 518.000 M 553.000 M 522.000 M 502.000 M 518.000 M 532.000 M 1.493 B
Changes in inventories 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -1.376 B -1.069 B -3.845 B -1.444 B -1.487 B -770.000 M -283.000 M -11.201 B
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other -14.000 M -289.000 M -467.000 M -57.000 M -20.000 M 5.000 M 129.000 M -172.000 M
Dividends Paid -1.950 B -1.986 B -1.953 B -1.951 B -2.050 B -2.077 B -2.031 B -2.018 B
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 861.000 M 791.000 M 783.000 M 937.000 M 1.328 B 764.000 M 987.000 M 1.033 B
Cash Change -1.238 B 5.702 B 3.315 B -1.370 B -4.586 B -659.000 M 10.187 B -3.570 B